{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:10:36Z","timestamp":1793949036811,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1053\/j.semvascsurg.2022.04.010","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:51:22Z","timestamp":1650923482000},"page":"180-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations"],"prefix":"10.1053","volume":"35","author":[{"given":"Roberto G.","family":"Aru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam C.","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0001","first-page":"1368","article-title":"Lower extremity arterial occlusive disease: epidemiology and natural history","author":"Conte","year":"2019","journal-title":"Rutherford's Vascular Surgery and Endovascular Therapy"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0002","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0003","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0741-5214(88)90273-X","article-title":"Factors affecting the patency of infrainguinal bypass","volume":"8","author":"Rutherford","year":"1988","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0741-5214(86)90073-X","article-title":"Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions","volume":"3","author":"Veith","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0003319706290732","article-title":"Predictors of failure of endovascular therapy for peripheral arterial disease","volume":"57","author":"Yacyshyn","year":"2006","journal-title":"Angiology"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0006","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcin.2014.01.168","article-title":"Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery","volume":"7","author":"Iida","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1583\/14-4721R.1","article-title":"Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions","volume":"21","author":"Iida","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0008","first-page":"549","article-title":"Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: the VIVA REALITY study","volume":"98","author":"Rocha-Singh","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0009","first-page":"1090e5","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0011","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty on the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0013","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon v. standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease. 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0014","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease. Twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0015","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the IN. PACT global study long lesion imaging cohort","volume":"11","author":"Scheinert","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1526602820942878","article-title":"Leaving nothing behind: no stent, no restenosis, no mortality","volume":"27","author":"Purushottam","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0018","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcin.2014.05.006","article-title":"Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study","volume":"7","author":"McKinsey","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1053\/j.semvascsurg.2022.04.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.carrev.2017.12.015","article-title":"Jetstream Atherectomy System treatment of femoropopliteal arteries: results of the post\u2013market JET Registry","volume":"19","author":"Gray","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jvs.2020.03.040","article-title":"Outcomes of rotational atherectomy in complex lesions of the superficial femoral artery","volume":"73","author":"Ponukumati","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0022","first-page":"355","article-title":"The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease","volume":"26","author":"Dattilo","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0023","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/1526602820935611","article-title":"Three-year outcomes of orbital atherectomy for the endovascular treatment of infrainguinal claudication or chronic limb-threatening ischemia","volume":"27","author":"Giannopoulos","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0024","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1526602820962972","article-title":"Three-year outcomes from the LIBERTY 360 study of endovascular interventions for peripheral artery disease stratified by Rutherford category","volume":"28","author":"Giannopoulos","year":"2021","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcin.2014.09.009","article-title":"Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis)","volume":"8","author":"Dippel","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0026","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2017.06.022","article-title":"Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions","volume":"70","author":"Brodmann","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0027","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/1526602818783989","article-title":"Safety and feasibility of intravascular lithotripsy for treatment of below-the-knee arterial stenoses","volume":"25","author":"Brodmann","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1526602820914598","article-title":"Intravascular lithotripsy for treatment of calcified infrapopliteal lesions: results from the Disrupt PAD III Observational Study","volume":"27","author":"Adams","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0029","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized Disrupt PAD III Trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jvs.2019.05.002","article-title":"Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease","volume":"70","author":"Mills","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0031","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jvs.2020.10.067","article-title":"Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines","volume":"73","author":"Bath","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0032","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jvs.2019.05.005","article-title":"Overuse of early peripheral vascular interventions for claudication","volume":"71","author":"Hicks","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0033","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jvs.2021.02.045","article-title":"Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates","volume":"74","author":"Madabhushi","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0034","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.jvs.2021.11.013","article-title":"Index atherectomy peripheral vascular interventions performed for claudication are associated with more reinterventions than nonatherectomy procedures","volume":"75","author":"Kawaji","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0035","first-page":"197","article-title":"Mechanisms underlying drug delivery in peripheral arteries","volume":"6","author":"Li","year":"2017","journal-title":"Intervent Cardiol Clin"},{"issue":"3","key":"10.1053\/j.semvascsurg.2022.04.010_bib0036","article-title":"Atherectomy for peripheral arterial disease","author":"Wardle","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0037","unstructured":"Class 1 device recall HawkOne. US Food and Drug Administration. Accessed January 15, 2022. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id =190894."},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0038","first-page":"1010","article-title":"Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-Laser TM IDE study","volume":"94","author":"Rundback","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1053\/j.semvascsurg.2022.04.010_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008434","article-title":"Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the Disrupt CAD II Study","volume":"12","author":"Ali","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jvs.2021.08.061","article-title":"Effect of intravascular ultrasound on clinical outcomes after thoracic endovascular aortic repair for blunt thoracic aortic injury","volume":"75","author":"Smith","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0041","series-title":"Endovascular Aortic Repair: Current Techniques with Fenestrated, Branched and Parallel Stent-Grafts","first-page":"95","article-title":"intravascular ultrasound to guide complex endovascular aortic repair","author":"Timaran","year":"2017"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0042","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0741-5214(98)70225-3","article-title":"Use of intravascular ultrasound improves long-term clinical outcome in the endovascular management of atherosclerotic aortoiliac occlusive disease","volume":"27","author":"Arko","year":"1998","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1053\/j.semvascsurg.2022.04.010_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.003700","article-title":"Outcomes with intravascular ultrasound-guided stent implantation: a meta analysis of randomized trials in the era of drug-eluting stents","volume":"9","author":"Elgendy","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0044","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.amjcard.2013.12.043","article-title":"Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies","volume":"113","author":"Ahn","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1538574420920998","article-title":"Utility of intravascular ultrasound in peripheral vascular interventions: systematic review and meta-analysis","volume":"54","author":"Sheikh","year":"2020","journal-title":"Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0046","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.avsg.2014.07.026","article-title":"A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions","volume":"29","author":"Hitchner","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0047","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.avsg.2014.10.011","article-title":"Technical and early outcomes using ultrasound-guided reentry for chronic total occlusions","volume":"29","author":"Baker","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0048","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1067\/mva.2002.119755","article-title":"Intravascular ultrasound scanning improves long-term patency of iliac lesions treated with balloon angioplasty and primary stenting","volume":"35","author":"Buckley","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0049","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0741-5214(96)80008-5","article-title":"Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries","volume":"23","author":"Tielbeek","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1753944717745509","article-title":"Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis","volume":"12","author":"Krishnan","year":"2018","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0051","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ehjcr\/ytaa568","article-title":"Intravascular ultrasound-guided shockwave lithotripsy of heavily calcified bilateral renal artery stenosis: a case report","volume":"5","author":"Yousif","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"4","key":"10.1053\/j.semvascsurg.2022.04.010_bib0052","first-page":"135","article-title":"Intravascular ultrasound-guided shockwave treatment of stents overlapping underexpansionof calcified left anterior descending artery","volume":"20","author":"Tripolino","year":"2019","journal-title":"J Cardiol Cases"},{"issue":"14","key":"10.1053\/j.semvascsurg.2022.04.010_bib0053","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jacc.2021.03.127","article-title":"The use of intravascular lithotripsy and intravascular ultrasound to aid percutaneous coronary intervention to a calcific vein graft","volume":"77","author":"Osheiba","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0054","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan Randomized Trial","volume":"25","author":"Iida","year":"2018","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0055","first-page":"664","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0056","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-Month Results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.semvascsurg.2022.04.010_bib0057","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0058","first-page":"1087","article-title":"Paclitaxel exposure: long-term safety and effectiveness of a drug-coated balloon for claudication in pooled randomized trials","volume":"96","author":"Schneider","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1053\/j.semvascsurg.2022.04.010_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0060","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable anti restenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0061","unstructured":"Brodmann M. RANGER II SFA Pivotal Trial, 12-month full cohort results 2020. Accessed January 2, 2022. https:\/\/www.bostonscientific.com\/content\/dam\/bostonscientific\/pi\/portfolio-group\/Stents\/Eluvia\/2020\/data-sheets\/Ranger%20SFA%20Clinical%20Data%20Sheet%20(PI-749406-AA).pdf."},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0062","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0063","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0064","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","article-title":"Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II Randomized Trial","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.carrev.2021.06.016","article-title":"Overview of the virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 drug-coated percutaneous transluminal angioplasty catheter for below-the-knee lesions in critical limb ischemia","volume":"33","author":"Case","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0066","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0067","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0068","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.avsg.2019.05.013","article-title":"Amputation-free survival in patients with critical limb ischemia treated with paclitaxel-eluting stents and paclitaxel-coated balloons","volume":"62","author":"Phair","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0069","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","article-title":"Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions","volume":"62","author":"Lammer","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1053\/j.semvascsurg.2022.04.010_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0071","unstructured":"Subgroup Analysis of VOYAGER PAD trial finds no mortality risk or benefit associated with drug-coated devices in PAD treatment. Endovascular Today. Published October 18, 2020. Accessed January 4, 2022. https:\/\/evtoday.com\/news\/subgroup-analysis-of-voyager-pad-trial-finds-no-mortality-risk-or-benefit-associated-with-drug-coated-devices-in-pad-treatment."},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0072","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor's choice\u2013long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0073","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejvs.2021.05.027","article-title":"Risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Katsanos","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0074","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.avsg.2018.11.023","article-title":"Comparison of spot versus long stenting for femoropopliteal artery disease","volume":"58","author":"Ko","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0075","first-page":"472","article-title":"Outcomes of spot stenting in versus long stenting after intentional subintimal approach for long chronic total occlusions of the femoropopliteal artery","volume":"8","author":"Hong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0076","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jvs.2018.12.044","article-title":"Spot stenting versus full coverage stenting after endovascular therapy of femoropopliteal artery lesions","volume":"70","author":"Tomoi","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0077","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.avsg.2019.02.018","article-title":"Combination of Rotarex thrombectomy and drug-coated balloon for the treatment of femoropopliteal artery in-stent restenosis","volume":"60","author":"Liao","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0078","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jvs.2020.02.043","article-title":"One-year results from the DETOUR I trial of the PQ Bypass DETOUR system for percutaneous femoropopliteal bypass","volume":"72","author":"Krievins","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0079","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1526602820921555","article-title":"New innovations and devices in the management of chronic limb-threatening ischemia","volume":"27","author":"Kim","year":"2020","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0080","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvsv.2020.12.080","article-title":"Venous outcomes at 1 year after using the femoral vein as a conduit for passage of percutaneous femoropopliteal bypass","volume":"9","author":"Schneider","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"10.1053\/j.semvascsurg.2022.04.010_bib0081","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jcin.2016.02.051","article-title":"Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I)","volume":"9","author":"Lammer","year":"2016","journal-title":"J Am Coll Cardiol Interv"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:40:46Z","timestamp":1760247646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796722000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0895796722000308"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.04.010","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations","name":"articletitle","label":"Article Title"},{"value":"Seminars in Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}